Author:
Wishart G.C,Gaston M,Poultsidis A.A,Purushotham A.D
Reference6 articles.
1. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women;Lancet,1992
2. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J. Clin. Oncol.,1999
3. The importance, availability and measurement of oestrogen receptor status in the management of breast cancer in the United Kingdom- results of a nationwide survey;Mander;Lancet,1998
4. Oestrogen receptor status—no longer an optional extra;Wishart;The Breast,1998
5. Immunohistochemical detection of steroid receptors in breast cancer;Leake;J. Clin. Path.,2000
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献